Time‐domain semi‐parametric estimation based on a metabolite basis set

A novel and fast time‐domain quantitation algorithm—quantitation based on semi‐parametric quantum estimation (QUEST)—invoking optimal prior knowledge is proposed and tested. This nonlinear least‐squares algorithm fits a time‐domain model function, made up from a basis set of quantum‐mechanically simulated whole‐metabolite signals, to low‐SNR in vivo data. A basis set of in vitro measured signals can be used too. The simulated basis set was created with the software package NMR‐SCOPE which can invoke various experimental protocols. Quantitation of 1H short echo‐time signals is often hampered by a background signal originating mainly from macromolecules and lipids. Here, we propose and compare three novel semi‐parametric approaches to handle such signals in terms of bias‐variance trade‐off. The performances of our methods are evaluated through extensive Monte‐Carlo studies. Uncertainty caused by the background is accounted for in the Cramér–Rao lower bounds calculation. Valuable insight about quantitation precision is obtained from the correlation matrices. Quantitation with QUEST of 1H in vitro data, 1H in vivo short echo‐time and 31P human brain signals at 1.5 T, as well as 1H spectroscopic imaging data of human brain at 1.5 T, is demonstrated. Copyright © 2005 John Wiley & Sons, Ltd.

[1]  D. Graveron-Demilly,et al.  Time-domain quantitation of 1H short echo-time signals: background accommodation , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.

[2]  Robert Bartha,et al.  Quantitative proton short‐echo‐time LASER spectroscopy of normal human white matter and hippocampus at 4 Tesla incorporating macromolecule subtraction , 2003, Magnetic resonance in medicine.

[3]  Wolfgang Grodd,et al.  Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases , 2003, Magnetic resonance in medicine.

[4]  J. Slotboom,et al.  Quantitative 1H‐magnetic resonance spectroscopy of human brain: Influence of composition and parameterization of the basis set in linear combination model‐fitting , 2002, Magnetic resonance in medicine.

[5]  C. Elster,et al.  Serial 1H-MRS in relapsing-remitting multiple sclerosis: effects of interferon-β therapy on absolute metabolite concentrations , 2002, Magnetic Resonance Materials in Physics, Biology and Medicine.

[6]  R E Kearney,et al.  Predicting surgical outcome in temporal lobe epilepsy patients using MRI and MRSI , 2002, Neurology.

[7]  A Gregory Sorensen,et al.  The potential of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis and management of patients with brain tumors , 2002, Current opinion in oncology.

[8]  Dirk van Ormondt,et al.  Cramer√© Rao-Bound Analysis of Spectroscopic Signal Processing Methods , 2002 .

[9]  P. Renshaw,et al.  Magnetic resonance spectroscopy: current and future applications in psychiatric research , 2002, Biological Psychiatry.

[10]  C. Clarke,et al.  Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes , 2001, European journal of neurology.

[11]  C Boesch,et al.  Characterization of the macromolecule baseline in localized 1H‐MR spectra of human brain , 2001, Magnetic resonance in medicine.

[12]  R. de Beer,et al.  Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals , 2001, Comput. Biol. Medicine.

[13]  S. Huffel,et al.  MR spectroscopy quantitation: a review of time‐domain methods , 2001, NMR in biomedicine.

[14]  B J Soher,et al.  Representation of strong baseline contributions in 1H MR spectra , 2001, Magnetic resonance in medicine.

[15]  U. Klose,et al.  Reliable detection of macromolecules in single‐volume 1H NMR spectra of the human brain , 2001, Magnetic resonance in medicine.

[16]  S. Provencher.  Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.

[17]  D van Ormondt,et al.  Cramér–Rao bounds: an evaluation tool for quantitation , 2001, NMR in biomedicine.

[18]  Ian Marshall,et al.  NMR Lineshapes and Lineshape Fitting Procedures , 2001 .

[19]  D. Graveron-Demilly,et al.  Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.

[20]  J. Pettegrew,et al.  Postprocessing method to segregate and quantify the broad components underlying the phosphodiester spectral region of in vivo 31P brain spectra , 2001, Magnetic resonance in medicine.

[21]  R. Menon,et al.  Comparison of the quantification precision of human short echo time 1H spectroscopy at 1.5 and 4.0 Tesla , 2000, Magnetic resonance in medicine.

[22]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[23]  van Ormondt D,et al.  Cramer-Rao bound expressions for parametric estimation of overlapping peaks: influence of prior knowledge , 2000, Journal of magnetic resonance (San Diego, Calif. 1997 : Print).

[24]  J R Griffiths,et al.  Monitoring pharmacokinetics of anticancer drugs: non-invasive investigation using magnetic resonance spectroscopy. , 2000, Advanced drug delivery reviews.

[25]  K. Nicolay,et al.  NMR spectroscopic evaluation of cerebral metabolism in hydrocephalus: A review , 2000, Neurological research.

[26]  D J Drost,et al.  Factors affecting the quantification of short echo in‐vivo 1H MR spectra: prior knowledge, peak elimination, and filtering , 1999, NMR in biomedicine.

[27]  B J Soher,et al.  Automated spectral analysis II: Application of wavelet shrinkage for characterization of non‐parameterized signals , 1998, Magnetic resonance in medicine.

[28]  B J Soher,et al.  Automated spectral analysis I: Formation of a priori information by spectral simulation , 1998, Magnetic resonance in medicine.

[29]  V. Govindaraju,et al.  Automated spectral analysis III: Application to in Vivo proton MR Spectroscopy and spectroscopic imaging , 1998, Magnetic resonance in medicine.

[30]  R. Buxton,et al.  Dynamics of blood flow and oxygenation changes during brain activation: The balloon model , 1998, Magnetic resonance in medicine.

[31]  S. Huffel,et al.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.

[32]  P. Williamson,et al.  The use of a priori knowledge to quantify short echo in vivo 1h mr spectra , 1995, Magnetic resonance in medicine.

[33]  K. Do,et al.  Efficient and Adaptive Estimation for Semiparametric Models. , 1994 .

[34]  K. Behar,et al.  Analysis of macromolecule resonances in 1H NMR spectra of human brain , 1994, Magnetic resonance in medicine.

[35]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[36]  P. Bickel.  Efficient and Adaptive Estimation for Semiparametric Models , 1993 .

[37]  André Briguet,et al.  Product-Operator Algebra for Strongly Coupled Spin Systems , 1993 .

[38]  D. van Ormondt,et al.  SVD-based quantification of magnetic resonance signals , 1992 .

[39]  James C. Spall,et al.  Parameter identification for state-space models with nuisance parameters , 1990 .

[40]  A. D. de Graaf,et al.  Quality: quantification improvement by converting lineshapes to the lorentzian type , 1990, Magnetic resonance in medicine.

[41]  P. Luyten,et al.  Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge , 1988, Magnetic resonance in medicine.

[42]  D. van Ormondt,et al.  Time-Domain Quantitation with a Metabolite Basis Set , 2003 .

[43]  G. Krueger,et al.  Time-Domain Fitting of 1 HMR Spectra of the Human Brain : A Model-Free Integration of the Macromolecular Baseline , 2002 .

[44]  D. van Ormondt,et al.  Background-signal Parameterization in In Vivo MR Spectroscopy , 2002 .

[45]  Dirk van Ormondt,et al.  Semiparametric Estimation for Metabolomics , 2000 .